Background: The prevalence of food allergy has been increasing, but treatment is very limited. DNA vaccination has been recognized as a promising method for the treatment of allergic diseases; however, poor immunogenicity has hindered its application. Methods: BALB/c mice were intradermally injected with plasmid DNA encoding the peanut protein Ara h 2 (pAra h 2) or pAra h 2 pretreated with poly-L- lysine (PLL) before or after sensitization with Ara h 2 protein. Ara h 2-specific antibodies were measured by ELISA. CD207+ dendritic cells (DCs) and Treg cells in draining lymph nodes were analyzed by flow cytometry after DNA immunization, and cytokine production in splenocytes was also analyzed. Results: In the prophylactic study, pretreatment with pAra h 2 or PLL-pAra h 2 resulted in lower levels of Ara h 2-specific IgG1, IgG2a, and IgE after sensitization with Ara h 2 protein, and mice in the PLL-pAra h 2 group had a significantly lower level of antibodies than those in the pAra h 2 group. In the treatment study, intradermal injection with pAra h 2 or PLL-pAra h 2 after Ara h 2 protein sensitization significantly decreased the level of Ara h 2-specific antibodies, and PLL- pAra h 2 had stronger effects than pAra h 2. There were increased numbers of CD207+ DCs and Treg cells in the mice receiving intradermal injection with PLL-pAra h 2, and splenocytes from PLL-pAra h 2-treated mice secreted increased levels of IFN-γ and IL-10. Conclusions: Modification of pAra h 2 with PLL improved its prophylactic and therapeutic effects in peanut-allergic mice.

Keywords:
Allergy vaccines, Animal models, Ara h 2, Peanut allergy, Polylysine, Regulatory T cells
1.
Nwaru BI, Hickstein L, Panesar SS, Roberts G, Muraro A, Sheikh A: Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy 2014;69:992-1007.
2.
Bublin M, Breiteneder H: Developing therapies for peanut allergy. Int Arch Allergy Immunol 2014;165:179-194.
3.
Wood RA: Food allergen immunotherapy: current status and prospects for the future. J Allergy Clin Immunol 2016;137:973-982.
4.
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, Brough HA, Phippard D, Basting M, Feeney M, Turcanu V, Sever ML, Gomez LM, Plaut M, Lack G: Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 2015;372:803-813.
5.
Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, Brough HA, Santos AF, Harris KM, Radulovic S, Basting M, Turcanu V, Plaut M, Lack G; Immune Tolerance Network LEAP-On Study Team: Effect of avoidance on peanut allergy after early peanut consumption. N Engl J Med 2016;374:1435-1443.
6.
Wavrin S, Bernard H, Wal J, Adel-Patient K: Cutaneous or respiratory exposures to peanut allergens in mice and their impacts on subsequent oral exposure. Int Arch Allergy Immunol 2014;164:189-199.
7.
Jones SM, Agbotounou WK, Fleischer DM, Burks AW, Pesek RD, Harris MW, Martin L, Thebault C, Ruban C, Benhamou PH: Safety of epicutaneous immunotherapy for the treatment of peanut allergy: a phase 1 study using the Viaskin patch. J Allergy Clin Immunol 2016;137:1258-1261.
8.
Hochreiter R, Stepanoska T, Ferreira F, Valenta R, Vrtala S, Thalhamer J, Hartl A: Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen. Eur J Immunol 2003;33:1667-1676.
9.
Hsu CH, Chua KY, Tao MH, Lai YL, Wu HD, Huang SK, Hsieh KH: Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 1996;2:540-544.
10.
Ludwig-Portugall I, Montermann E, Kremer A, Reske-Kunz AB, Sudowe S: Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination. J Allergy Clin Immunol 2004;114:951-957.
11.
Roy K, Mao HQ, Huang SK, Leong KW: Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5:387-391.
12.
Peng HJ, Su SN, Chang ZN, Chao PL, Kuo SW, Tsai LC: Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Der f 11. Vaccine 2002;20:1761-1768.
13.
Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M, Swain SL, Spiegelberg HL, Carson DA: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996;93:5141-5145.
14.
Hartl A, Hochreiter R, Stepanoska T, Ferreira F, Thalhamer J: Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a. Allergy 2004;59:65-73.
15.
Zhou B, Ensell M, Zhou Y, Nair U, Glickstein J, Kermany MH, Cai Q, Cai C, Liu W, Deng YP, Kakigi A, Barbieri M, Mora M, Kanangat S, Yoo TJ: Prevention and treatment of DNA vaccine encoding cockroach allergen Bla g 1 in a mouse model of allergic airway inflammation. Allergy 2012;67:166-174.
16.
Fissolo N, Costa C, Nurtdinov RN, Bustamante MF, Llombart V, Mansilla MJ, Espejo C, Montalban X, Comabella M: Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis. J Neuroinflammation 2012;9:139.
17.
Li L, Saade F, Petrovsky N: The future of human DNA vaccines. J Biotechnol 2012;162:171-182.
18.
Lächelt U, Wagner E: Nucleic acid therapeutics using polyplexes: a journey of 50 years (and beyond). Chem Rev 2015;115:11043-11078.
19.
Behnecke A, Li W, Chen L, Saxon A, Zhang K: IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor. J Allergy Clin Immunol 2009;124:108-113.
20.
Shi C, He Y, Feng X, Fu D: ε-Polylysine and next-generation dendrigraft poly-L-lysine: chemistry, activity, and applications in biopharmaceuticals. J Biomater Sci Polym Ed 2015;26:1343-1356.
21.
Porterfield HS, Murray KS, Schlichting DG, Chen X, Hansen KC, Duncan MW, Dreskin SC: Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants. Clin Exp Allergy 2009;39:1099-1108.
22.
Kulis M, Chen X, Lew J, Wang Q, Patel OP, Zhuang Y, Murray KS, Duncan MW, Porterfield HS, W Burks A, Dreskin SC: The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice. Clin Exp Allergy 2012;42:326-336.
23.
Chang LM, Song Y, Li X, Sampson HA, Masilamani M: Dietary elimination of soybean components enhances allergic immune response to peanuts in BALB/c mice. Int Arch Allergy Immunol 2015;166:304-310.
24.
Li W, Zhang Z, Saxon A, Zhang K: Prevention of oral food allergy sensitization via skin application of food allergen in a mouse model. Allergy 2012;67:622-629.
25.
Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA, et al: Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994;91:9519-9523.
26.
Saade F, Petrovsky N: Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2014;11:189-209.
27.
Kwoh DY, Coffin CC, Lollo CP, Jovenal J, Banaszczyk MG, Mullen P, Phillips A, Amini A, Fabrycki J, Bartholomew RM, Brostoff SW, Carlo DJ: Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys Acta 1999;1444:171-190.
28.
Desmedt M, Rottiers P, Dooms H, Fiers W, Grooten J: Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J Immunol 1998;160:5300-5308.
29.
Pouton CW, Lucas P, Thomas BJ, Uduehi AN, Milroy DA, Moss SH: Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J Control Release 1998;53:289-299.
30.
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL: Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-1468.
31.
Hiraki J, Ichikawa T, Ninomiya S, Seki H, Uohama K, Seki H, Kimura S, Yanagimoto Y, Barnett JJ: Use of ADME studies to confirm the safety of epsilon-polylysine as a preservative in food. Regul Toxicol Pharmacol 2003;37:328-340.
32.
Pfutzner W: Allergen-specific tolerance induction: of mice and men. Int Arch Allergy Immunol 2015;166:81-83.
33.
Li X, Srivastava K, Grishin A, Huang C, Schofield B, Burks W, Sampson HA: Persistent protective effect of heat-killed Escherichia coli producing engineered recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 2003;112:159-167.
34.
Akdis CA, Akdis M: Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest 2014;124:4678-4680.
35.
Yamamoto T, Fujiwara K, Tsubota Y, Kageyama-Yahara N, Hayashi S, Kadowaki M: Induction of regulatory T cells as a novel mechanism underlying the therapeutic action of kakkonto, a traditional Japanese herbal medicine, in a murine food allergy model. Int Arch Allergy Immunol 2016;169:146-156.
36.
Pellerin L, Jenks JA, Bégin P, Bacchetta R, Nadeau KC: Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 2014;58:358-368.
37.
Syed A, Garcia MA, Lyu S, Bucayu R, Kohli A, Ishida S, Berglund JP, Tsai M, Maecker H, O'Riordan G, Galli SJ, Nadeau KC: Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 2014;133:500-510.
38.
Taylor A, Akdis M, Joss A, Akkoc T, Wenig R, Colonna M, Daigle I, Flory E, Blaser K, Akdis CA: IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J Allergy Clin Immunol 2007;120:76-83.
39.
Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N, Tripp CH, Douillard P, Leserman L, Kaiserlian D, Saeland S, Davoust J, Malissen B: Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005;22:643-654.
40.
Li X, Huang CK, Schofield BH, Burks AW, Bannon GA, Kim KH, Huang SK, Sampson HA: Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J Immunol 1999;162:3045-3052.
41.
Parvataneni S, Gonipeta B, Acharya HG, Gangur V: An adjuvant-free mouse model of transdermal sensitization and oral elicitation of anaphylaxis to shellfish. Int Arch Allergy Immunol 2015;168:269-276.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.